Use of SGLT2i versus DPP4i as an Add-On Therapy and the Risk of PAD-Related Surgical Events (Amputation, Stent Placement, or Vascular Surgery): A Cohort Study in Veterans with Diabetes
Created in BioRender. Griffin, K. (2024) https://app.biorender.com/citation/6733794a3c784a5af0103753
Copy bibliographic reference (APA Style)
Griffin, K. (2024). Use of SGLT2i versus DPP4i as an Add-On Therapy and the Risk of PAD-Related Surgical Events (Amputation, Stent Placement, or Vascular Surgery): A Cohort Study in Veterans with Diabetes. Created in BioRender. https://app.biorender.com/citation/6733794a3c784a5af0103753